Treatment(s) now being considered-Hormonal therapy - Page 7 of 8 Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Hormonal therapy Posts on Medivizor

Benefits of postoperative chemotherapy vary according to breast cancer type

Benefits of postoperative chemotherapy vary according to breast cancer type

Posted by on Feb 25, 2013 in Breast cancer | 0 comments

In a nutshell This study questioned the benefit of adding chemotherapy to postoperative hormonal treatment in the case of lobular breast cancer. Their findings were that chemotherapy seems to offer no additional beneficial effects in women with lobular breast cancer receiving hormonal therapy. Some background There are two main types of breast...

Read More

Postoperative radiotherapy prevents breast cancer recurrence and prolongs survival

Posted by on Feb 25, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated if strategies to prevent cancer recurrence are associated with prolonged survival 15 years after treatment. Their main findings were that postoperative radiation managed to prevent cancer recurrence and was associated with higher rates of long-term survival. Some background Early breast cancer is often treated...

Read More

Personalizing breast cancer treatment based on the genetic “finger-print” of the tumor

Personalizing breast cancer treatment based on the genetic “finger-print” of the tumor

Posted by on Feb 25, 2013 in Breast cancer | 0 comments

This article discusses how tests such as the Oncotype DX or Mammaprint can be used to design individual treatment plans for patients with breast cancer. Patients with stage I and stage II breast cancer are treated similarly. Following surgical removal of a breast tumor, systemic (body-wide) treatment is often used.  This secondary treatment is...

Read More

Focal Ultrasound-based therapy for prostate cancer as means to reduced genito-urinary side effects

Focal Ultrasound-based therapy for prostate cancer as means to reduced genito-urinary side effects

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This study evaluated whether focal Ultrasound-based therapy of individual cancer lesions can minimize the side effects associated with radical therapy that involves the whole prostate gland. Main findings: Focused therapy directed into cancer tissues significantly reduces genitourinary side effects like urine-leakage and impotence. Some...

Read More

Treatment options for localized prostate cancer – comparing long-term adverse effects

Treatment options for localized prostate cancer – comparing long-term adverse effects

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This study aimed to identify health-related decline in quality of life 4 to 8 years after prostate cancer (PC) treatment. Main finding: measures of quality of life vary based on therapy choice. Some background Treatments for localized PC (confined to the prostate gland) include radical prostatectomy (RP), brachytherapy (BT) and...

Read More

Does Tamoxifen reduce the risk of cancer in a second breast in BRCA1 and BRCA2 carriers?

Does Tamoxifen reduce the risk of cancer in a second breast in BRCA1 and BRCA2 carriers?

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell The risk of breast cancer is high (~80%) in women who inherit a damaged (mutated) gene called BRCA1 or BRCA 2 (‘BRCA carriers’). Following the first diagnosis, their risk of developing another tumor in the second breast within 10 years is 30%. Some background Some types of breast cancer need estrogen (female sex...

Read More

Sexual, urinary, hormonal and bowel function – a comparison between prostate cancer survivors and noncancer men

Sexual, urinary, hormonal and bowel function – a comparison between prostate cancer survivors and noncancer men

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell The present study compared survivors of prostate cancer (PC) to patients of similar sexes and ages that have not had prostate cancer (non-cancer controls) based on the effects of prior treatments and treatment options on sexual, urinary, bowel and hormone functions. The main finding was that PC survivors had poorer sexual and urinary...

Read More

Prostatectomy and radiation effects on urinary, bowel and erectile dysfuntion 2, 5 and 15 years after prostate cancer diagnosis

Prostatectomy and radiation effects on urinary, bowel and erectile dysfuntion 2, 5 and 15 years after prostate cancer diagnosis

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This paper evaluated the long-term influence of prostate cancer treatment with prostatectomy or radiotherapy on urinary, bowel and sexual function. Prostatectomy was associated with a higher rate of urinary and erectile dysfunction, whereas radiotherapy caused more frequent bowel urgency at 2 and 5 years after diagnosis. Some background...

Read More

Risks of Incontinence and Sexual Dysfunction following Robotic or Open surgical removal of the prostate : A Comparison study

Risks of Incontinence and Sexual Dysfunction following Robotic or Open surgical removal of the prostate : A Comparison study

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell The present study compared the risks of urinary incontinence (loss of bladder control) and sexual dysfunction following two techniques of radical prostatectomy (complete surgical removal of the prostate gland): traditional open procedure versus robotic-minimally invasive surgery. Main findings: the risks tested were comparably...

Read More